Introduction
============

Inflammatory bowel disease (IBD) such as Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the digestive tract with unknown etiology. Genetic and environmental factors have been correlated with the pathogenesis of IBD,^([@B1]--[@B3])^ but the precise mechanisms remain unclear. Clinical symptoms in patients with CD include diarrhea, abdominal pain, weight loss, and other abdominal symptoms due to bowel obstruction. UC is associated with symptoms including bloody diarrhea, abdominal pain, weight loss, and fever. Furthermore, inflammation of the digestive tract and the aforementioned abdominal symptoms often lead to malnutrition. Patients with IBD have various nutritional and metabolic disturbances. Emaciation is found in 20--70% of hospitalized CD patients,^([@B4],[@B5])^ and approximately 75% of hospitalized CD patients are undernourished,^([@B6],[@B7])^ indicating that nutritional support is essential for CD patients. Nutritional therapies such as enteral nutrition (EN), total parenteral nutrition (TPN), and anti-tumor necrosis factor (TNF)-α treatment are useful induction therapies for CD patients. Although TPN is useful for bowel rest in the active stage of UC, EN does not induce or maintain remission in UC. Therefore, corticosteroids and immunosuppressive drugs are efficacious treatment options for UC patients.

It is generally accepted that the prevalence of nutritional deficiencies and malnutrition are higher in patients with CD than in patients with UC.^([@B8])^ Han *et al.*^([@B9])^ reported that the prevalence of weight loss, hypoalbuminemia, and intestinal protein loss was higher in patients with CD than in patients with UC. However, there are few reports about comparison of nutritional status between CD and UC patients except for this report. Protein energy malnutrition detected as body weight loss and hypoalbuminemia are observed in both CD and in UC patients.

Several studies have investigated the role of energy metabolism in patients with IBD. For example, there are reports that energy metabolism shifts to a hyper-metabolic state in CD patients.^([@B10]--[@B14])^ However, Schneeweiss *et al.*^([@B15])^ indicated that measured resting energy expenditure (mREE) was not significantly different between CD patients and healthy controls. There are a few reports that have analyzed energy metabolism in patients with UC,^([@B16],[@B17])^ and there have not been studies identifying the relationship between nutritional status and energy metabolism in IBD patients. Recently, we used indirect calorimetry to identify that mREEs of Japanese IBD patients were significantly higher than that of healthy controls.^([@B18],[@B19])^ Here, we are the first to describe a comparative analysis of the nutritional status and energy metabolism of hospitalized patients with CD and UC.

Subjects and Methods
====================

Patients
--------

Twenty-two patients with CD and 18 patients with UC were enrolled in this study. The patients were admitted to the Gastroenterology Unit of the Shiga University of Medical Science Hospital between June 2011 and March 2014. The ethics committee of the Shiga University of Medical Science approved this study. All diagnoses of CD and UC were established by using radiological, endoscopic, histological, and clinical criteria.^([@B20],[@B21])^

Methods
-------

The following values were measured upon admission: 1) Anthropometrics: height (cm), weight (kg), body mass index (BMI) (kg/m^2^). 2) Nutritional screening: subjective global assessment (SGA),^([@B22],[@B23])^ malnutrition universal screening tool (MUST),^([@B24])^ nutritional risk screening 2002 (NRS2002),^([@B25])^ prognostic nutritional index (PNI) (10 × albumin (g/dl) + 0.005 × total lymphocyte count per cubic mm),^([@B26])^ and controlling nutritional status (CONUT).^([@B27])^ 3) Laboratory tests: levels of total protein (g/dl), albumin (g/dl), total cholesterol (mg/dl), triglyceride (mg/dl), hemoglobin (g/dl), C-reactive protein (CRP) (mg/dl). 4) Activity index: Crohn's Disease Activity index (CDAI) for CD,^([@B28],[@B29])^ Lichtiger index and Seo index for UC.^([@B30],[@B31])^ 5) Energy metabolism measured by indirect calorimetry: mREE (kcal/kg/day), respiratory quotients (RQ). 6) Inflammatory cytokines: TNF-α (pg/dl) and interleukin-6 (IL-6) (pg/dl) were determined by using commercially available ELISA kits (R&D Systems, Minneapolis, MN).

Indirect calorimetry
--------------------

mREEs and RQ were measured by using computed open-circuit indirect calorimetry (AE-300S; Minato Medical Science Co., Osaka, Japan).^([@B18],[@B19],[@B32]--[@B34])^ Indirect calorimetry was performed in the same ward in the hospital after an 8 h fast. Infusion of parenteral nutrition (PN) was continuous and period flow and gas calibration were performed prior to the measurements. After resting for a minimum of 30 min, the patients were assessed in a supine position with a facemask by using a pump that drew ambient air through the facemask at a constant rate. After equilibrium was reached for 10 min, respiratory exchange was performed continuously over a 30 min period. The mREE and RQ data were obtained every minute. The mREE was calculated from oxygen consumption (VO~2~) and carbon dioxide production (VCO~2~) by using the following Weir equation: mREE = (3.94 × VO~2~ + 1.11 × VCO~2~) × 1.44. Measurement of RQ was calculated as RQ = VCO~2~/VO~2~. The mREE was then compared with the predicted resting energy expenditure (pREE) by using the Harris-Benedict equation for men {pREE = 66.47 + 13.75 × W \[weight (kg)\] + 5.0 × H \[height (cm)\] -- 6.75 × A \[age (years)\]} and women {pREE = 665.09 + 9.56 × W \[weight (kg)\] + 1.84 × H \[height (cm)\] -- 4.67 × A \[age (years)\]}.

Statistical analyses
--------------------

Statistical analyses were performed by using the Chi-square test when appropriate. Student's paired *t* tests were used for the statistical analysis of parametric data, and the Mann-Whitney *U* test was used for the statistical analysis of nonparametric data. Correlation was investigated by using Spearman rank correlation tests. Results are presented as mean ± SD, and a *p* value \<0.05 was considered statistically significant.

Results
=======

Patient characteristics
-----------------------

Patient's characteristics are shown in Table [1](#T1){ref-type="table"}. We excluded one subject (UC patient with BMI 28.8 kg/m^2^) with a BMI ≥25 kg/m^2^. There was no significant difference in mean age, height, body weight, and BMI between CD and UC patients. In CD patients, 7 patients (32%) had mild to moderate disease (CDAI \<220), and 15 patients (68%) had moderate to severe disease (CDAI 220--450). The Lichtiger index demonstrated that 9 UC patients (50%) had mild/moderate disease (Lichtiger index \<11), and 9 UC patients (50%) had severe disease (Lichtiger index ≥11). Results from the Seo index identified eight patients (44%) with moderate disease (Seo index \<220), and 10 patients (56%) with severe disease (Seo index ≥220). Seventeen patients with CD and 11 patients with UC received TPN, 5 patients with CD and 7 patients with UC received peripheral parenteral nutrition. Twenty-one patients with CD switched to EN from PN after treatment. The number of surgical operations performed was significantly more in CD patients than in UC patients.

Nutritional screening
---------------------

As shown in Table [2](#T2){ref-type="table"}, according to SGA, 41.0% of CD patients and 33.3% of UC patients were considered severely malnourished. According to MUST, 68.2% of CD patients and 61.1% of UC patients were at high risk for malnutrition. CD patients were frequently qualified as severely malnourished by SGA detection and high-risk by MUST when compared to UC patients, but there were no significant difference between the patients for these parameters (*p* = 0.545, *p* = 0.767). According to NRS2002, 77.3% of CD patients and 83.3% of UC patients were considered at risk for malnutrition. Body weight loss over the 6-month period in CD and UC patients was 9.7 ± 6.8% and 7.1 ± 6.5%, respectively, although there was no significant difference between the groups (*p* = 0.737). According to PNI, 90.9% of CD patients and 83.3% of UC patients were considered at high risk (PNI ⩽40). The mean PNI in CD and UC patients was 34.0 ± 5.6 and 32.5 ± 6.9, respectively. According to CONUT, 36.4% of CD and 44.5% of UC patients were considered severe, and the mean CONUT in CD and UC patients was 7.50 ± 2.9 and 8.0 ± 3.3, respectively. There was no significant difference in PNI and CONUT between CD and UC patients.

Laboratory tests and inflammatory cytokines
-------------------------------------------

Total protein in UC patients (5.8 ± 0.6 g/dl) was significantly decreased compared to that in CD patients (6.4 ± 0.8 g/dl). There were 54.5% and 83.3% of CD and UC patients with serum albumin levels \<3.0 g/dl (*p* = 0.053), and 72.7% and 66.7% with total cholesterol levels \<140 mg/dl (*p* = 0.677), respectively. The results also indicated that 73.7% and 66.7% of CD and UC patients, respectively, had plasma IL-6 levels \>4 pg/ml. Furthermore, 11.1% and 37.5% of CD and UC patients had serum TNF-α levels \>2.8 pg/ml, respectively. There were no significant differences in the laboratory tests and inflammatory cytokines for CD and UC patients except for serum total protein (Table [3](#T3){ref-type="table"}).

Energy metabolism and its relationship to disease activity
----------------------------------------------------------

In CD patients, mREE determined by indirect calorimetry was 1388.7 ± 226.6 kcal/day and pREE calculated by the Harris-Benedict equation was 1413.1 ± 127.9 kcal/day. In UC patients, mREE was 1341.6 ± 252.6 kcal/day and pREE was 1324.6 ± 174.8 kcal/day. There were no significant differences in mREE/body weight and RQ between CD and UC patients (Table [4](#T4){ref-type="table"}).

In CD patients, there was no significant correlation between mREE/body weight and disease activity index (Fig. [1](#F1){ref-type="fig"}). However, there was a positive correlation between mREE/body weight and activity index in UC patients (Fig. [2](#F2){ref-type="fig"}). In both CD and UC patients, there was no significant correlation between CRP levels and mREE/body weight or CRP levels and mREE/pREE. Results in Fig. [3](#F3){ref-type="fig"} indicate a positive correlation between IL-6 levels and mREE/pREE or mREE/body weight in CD patients. Furthermore, in UC patients, there was a positive tendency of correlation between IL-6 levels and mREE/pREE (*p* = 0.062) (Fig. [4](#F4){ref-type="fig"}). However, there was no significant correlation between TNF-α levels and mREE/pREE or mREE/body weight in CD and UC patients.

Discussion
==========

It is well known that malnutrition is a significant health problem in IBD patients. It is also accepted that the prevalence of nutritional deficiencies and malnutrition is higher in patients with CD than in patients with UC. It has been hypothesized that increased malnutrition in CD patients is associated with transmural inflammation of the gastrointestinal tract while UC is characterized by inflammation limited to the colonic mucosa. However, despite the indisputable role of IBD in malnutrition, there are few reports on the comparative analysis of nutritional status and energy metabolism of CD and UC patients. One report by Han *et al.*^([@B9])^ demonstrated a high prevalence of abnormal laboratory tests including serum albumin and micronutrient levels in CD patients. In our study, we investigated laboratory tests and nutritional status by using SGA, MUST, NRS2002, PNI, and CONUT. Here, we clearly demonstrated that the nutritional condition of hospitalized UC patients is poor and almost equal to that of CD patients.

Mijac *et al.*^([@B35])^ reported no significant difference in nutritional parameters between CD and UC patients except for lower mid-arm muscle circumference in UC patients. However, patients enrolled in their study were well nourished compared to patients enrolled in our study, and had BMI and serum albumin levels 21.4 ± 3.7 kg/m^2^ and 3.1 ± 0.7 g/dl, respectively. Conversely, in our study, the mean BMI was 18.9 ± 2.5 kg/m^2^, and serum albumin levels were 2.7 ± 0.5 g/dl. Furthermore, Mijac *et al.* and colleagues conducted their study in Serbia where the prevalence of men and women over 20 years old who are overweight or obese was higher than 50%.^([@B36])^ In Japan, the prevalence of men and women over 20 years old who are overweight or obese is 28.9% and 17.6%, respectively. Additionally, our study enrolled IBD patients with severe disease and a compromised nutritional status, and the apparent difference in race should be taken into account when comparing the studies. In this study, we identified no significant difference in the nutritional status of CD and UC patients, which is supported by results published by Mijac *et al.*^([@B35])^ However, both groups demonstrated risk for malnourishment, highlighting the necessity of nutritional management in both patients with active CD and UC, although the number of patients in this study was not large as Mijac's study.

This is the first report to compare resting energy expenditure in CD and UC patients although several reports have documented that IBD patients exhibit energy metabolism shifts to a hyper-metabolic status.^([@B10]--[@B14],[@B16],[@B17])^ Previously, we reported that Japanese IBD patients had significantly higher mREE when compared to healthy controls by using indirect calorimetry.^([@B18],[@B19])^ In this study, there was no significant difference in mREE or RQ between CD and UC patients. However, a positive correlation between mREE and disease activity was identified in UC patients.

Several studies have investigated the relationship between energy metabolism and disease activity in CD patients. For example, Wiskin *et al.*^([@B37])^ reported that there was no relationship between disease activity and mREE or CRP in childhood CD patients. Recently, Gong *et al.*^([@B38])^ also reported no significant correlation between mREE and disease activity when using CDAI in adult CD patients. In our study, we showed there was no relationship between energy metabolism and CDAI or CRP in CD patients, which is supported by observations from previous studies. However, in UC patients, the relationship between energy metabolism and disease activity had not been thoroughly investigated. Previously, we reported a positive correlation between mREE and the Lichtiger index in UC patients.^([@B19])^ Here, we clearly demonstrated that energy metabolism correlated with the Lichtiger and Seo indices, and we confirmed that disease activity affected the energy metabolism in UC patients. These results suggest that nutritional status of UC patients is determined by energy requirements according to disease activity.

It has been shown that disease activity and CRP levels are not always linked in active IBD patients.^([@B39],[@B40])^ Our results presented here indicate no significant correlation between mREE and CRP levels in CD and UC patients. This confirms previous study by Wiskin *et al.*^([@B41])^ who identified no significant correlation between mREE and CRP levels in children with IBD.

The results in this study showed that energy expenditure was correlated with IL-6 levels, but not with TNF-α levels. Pro-inflammatory cytokines significantly affect energy metabolism in patients with systemic inflammatory diseases including IBD.^([@B42],[@B43])^ Previously, we reported that IL-6 levels correlated with energy metabolism in CD patients.^([@B34])^ In this study, IL-6 levels correlated with mREE/pREE in CD patients (*p*\<0.05) and UC patients (*p* = 0.062). In CD patients, serum IL-6 level but not serum TNF-α level was reported to be important marker as disease activity.^([@B44])^ Furthermore, it was reported that the increased production of proinflammatory cytokines, particularly of IL-6 and IL-8, play an important role in the pathogenesis of UC.^([@B45])^ In this study, we demonstrate that energy metabolism correlated to IL-6 levels in CD and UC patients. Kotani *et al.*^([@B46])^ reported that mREE/pREE was significantly correlated to IL-6 levels and was not correlated with TNF-α levels after surgical trauma.

In conclusion, hospitalized CD and UC patients exhibited severe nutritional status and had similar energy expenditure. However, energy expenditure significantly correlated with disease activity in UC patients, but not in CD patients. Therefore, it is important to determine the daily energy requirements correlated with disease activity for active UC patients in order to improve nutritional conditions for these patients.
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![Correlation between measured resting energy expenditure/body weight (mREE/body weight) and the Lichtiger and Seo indices in UC patients. The mREE/body weight in UC patients exhibited positive correlation with both the Lichtiger index (A) and Seo index (B).](jcbn14-95f02){#F2}

![Correlation between interleukin-6 (IL-6) levels and tumor necrosis factor-α (TNF-α) levels and measured resting energy expenditure/predicted resting energy expenditure (mREE/pREE) or mREE/body weight in CD patients. IL-6 levels in CD patients exhibited positive correlation with mREE/pREE (A) and mREE/body weight (B). However, there was no significant correlation between TNF-α and mREE/pREE (C) or mREE/body weight (D) in CD patients.](jcbn14-95f03){#F3}

![Correlation between interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels and measured resting energy expenditure/predicted resting energy expenditure (mREE/pREE) or mREE/body weight in UC patients. IL-6 levels in UC patients exhibited positibe correlation with mREE/pREE (*p* = 0.062) (A). However, there was no significant correlation between IL-6 and mREE/body weight (B), or correlation between TNF-α and mREE/pREE (C) or mREE/body weight (D) in UC patients.](jcbn14-95f04){#F4}

###### 

Characteristics of patients with IBD (*n* = 40)

  Characteristics                                CD patients (*n* = 22)   UC patients (*n* = 18)   *p* value
  ---------------------------------------------- ------------------------ ------------------------ -----------
  Gender (male/female)                           16/6                     12/6                     
  Age (years)                                    30.8 ± 9.5               39.4 ± 16.9              0.064
  Height (cm)                                    168.5 ± 7.5              163.5 ± 8.7              0.062
  Body weight (kg)                               53.0 ± 6.4               51.2 ± 8.9               0.466
  BMI (kg/m^2^)                                  18.7 ± 2.5               19.1 ± 2.5               0.643
  Type of CD (ileal/ileocolitic/colitic)         6/13/3                   ---                      
  Type of UC (total colitis/left-side colitis)   ---                      12/6                     
  Activity index                                                                                   
   CDAI for CD                                   255.0 ± 88.7             ---                      
   Seo index for UC                              ---                      222.2 ± 33.5             
   Lichtiger index for UC                        ---                      11.3 ± 2.8               
  Treatments                                                                                       
   PSL ≥20 mg/day                                5                        16                       
      \<20 mg/day                                17                       2                        
   Azathioprine or Cyclosporine                  10                       12                       
   Leukocytapheresis                             0                        10                       
   Anti-TNF-α                                    18                       2                        
  Nutritional therapy                                                                              
   TPN/PPN                                       17/5                     11/7                     0.267
   EN (switched from PN)                         21                       ---                      
  Surgical operation                             9                        1                        0.010
  Duration of the disease (years)                4.6 ± 6.0                3.6 ± 6.1                0.642

IBD, inflammatory bowel disease; CD, Crohn's disease; UC, ulcerative colitis; BMI, body mass index; CDAI, Crohn's Disease Activity Index; PSL, prednisolone; anti-TNF-α, anti-tumor necrosis factor-α; TPN, total parenteral nutrition; PPN, peripheral parenteral nutrition; EN, enteral nutrition; PN, parenteral nutrition. Each value represents the mean ± SD.

###### 

Nutritional screening

                              CD patients (%)   UC patients (%)   *p* value
  --------------------------- ----------------- ----------------- -----------
  SGA                                                             
   Well nourished             4.5               0                 0.545
   Moderately malnourished    54.5              66.7              
   Severely malnourished      41.0              33.3              
  MUST                                                            
   Low risk                   13.6              11.1              0.767
   Medium risk                18.2              27.8              
   High risk                  68.2              61.1              
  NRS2002                                                         
   Without nutritional risk   22.7              16.7              0.634
   With nutritional risk      77.3              83.3              
  PNI                                                             
   Low risk                   9.1               16.7              0.471
   High risk                  90.9              83.3              
  CONUT                                                           
   Normal                     4.5               11.1              0.766
   Light                      13.6              11.1              
   Moderate                   45.5              33.3              
   Severe                     36.4              44.5              

SGA, subjective global assessment; MUST, malnutrition universal screening tool; NRS2002, nutritional risk screening 2002; PNI, prognostic nutritional index; CONUT, controlling nutritional status.

###### 

Laboratory tests and inflammatory cytokines

                           CD patients    UC patients    *p* value
  ------------------------ -------------- -------------- -----------
  Laboratory tests                                       
   TP (g/dl)               6.4 ± 0.8      5.8 ± 0.6      0.009
   Alb (g/dl)              2.8 ± 0.5      2.6 ± 0.6      0.234
   T-cho (mg/dl)           127.5 ± 31.8   125.9 ± 36.5   0.882
   TG (mg/dl)              82.9 ± 31.1    90.0 ± 57.5    0.292
   Hb (g/dl)               11.0 ± 2.0     10.3 ± 3.0     0.430
   CRP (mg/dl)             6.6 ± 6.8      6.1 ± 5.5      0.925
  Inflammatory cytokines                                 
   IL-6 (pg/ml)            13.8 ± 13.4    17.0 ± 14.0    0.506
   TNF-α (pg/ml)           2.0 ± 0.7      2.7 ± 1.7      0.108

TP, total protein; Alb, albumin; T-cho, total cholesterol; TG, triglyceride; Hb, hemoglobin; CRP, C-reactive protein; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α. Each value represents the mean ± SD.

###### 

Energy metabolism

                                   CD patients       UC patients       *p* value
  -------------------------------- ----------------- ----------------- -----------
  mREE (kcal/day)                  1,388.7 ± 226.6   1,341.6 ± 252.6   0.538
  pREE (kcal/day)                  1,413.1 ± 127.9   1,324.6 ± 174.8   0.072
  mREE/body weight (kcal/kg/day)   26.3 ± 3.8        26.3 ± 3.0        0.986
  pREE/body weight (kcal/kg/day)   26.8 ± 2.1        26.1 ± 2.8        0.378
  mREE/pREE                        0.98 ± 0.13       1.01 ± 0.13       0.475
  RQ                               0.81 ± 0.07       0.79 ± 0.09       0.377

mREE, measured resting energy expenditure; pREE, predicted resting energy expenditure; RQ, respiratory quotient. Each value represents the mean ± SD.
